BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 31332862)

  • 1. Small GTPase RHOE/RND3, a new critical regulator of NF-κB signalling in glioblastoma multiforme?
    Sun Q; Dong H; Li Y; Yuan F; Xu Y; Mao S; Xiong X; Chen Q; Liu B
    Cell Prolif; 2019 Sep; 52(5):e12665. PubMed ID: 31332862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of RND3/RhoE in glioblastoma patients promotes tumorigenesis through augmentation of notch transcriptional complex activity.
    Liu B; Lin X; Yang X; Dong H; Yue X; Andrade KC; Guo Z; Yang J; Wu L; Zhu X; Zhang S; Tian D; Wang J; Cai Q; Chen Q; Mao S; Chen Q; Chang J
    Cancer Med; 2015 Sep; 4(9):1404-16. PubMed ID: 26108681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RND3 promotes Snail 1 protein degradation and inhibits glioblastoma cell migration and invasion.
    Liu B; Dong H; Lin X; Yang X; Yue X; Yang J; Li Y; Wu L; Zhu X; Zhang S; Tian D; Wang J; Cai Q; Mao S; Chen Q; Chang J
    Oncotarget; 2016 Dec; 7(50):82411-82423. PubMed ID: 27705942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic deletion of Rnd3 suppresses apoptosis through NF‑κB signaling in the brain.
    Dong H; Sun Q; Zhang Y; Li Y; Yuan F; Mao S; Liu B
    Oncol Rep; 2021 Feb; 45(2):595-605. PubMed ID: 33416158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RND2 attenuates apoptosis and autophagy in glioblastoma cells by targeting the p38 MAPK signalling pathway.
    Xu Y; Sun Q; Yuan F; Dong H; Zhang H; Geng R; Qi Y; Xiong X; Chen Q; Liu B
    J Exp Clin Cancer Res; 2020 Aug; 39(1):174. PubMed ID: 32867814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The positive regulatory loop of TCF4N/p65 promotes glioblastoma tumourigenesis and chemosensitivity.
    Hu Y; Zhang B; Lu P; Wang J; Chen C; Yin Y; Wan Q; Wang J; Jiao J; Fang X; Pu Z; Gong L; Ji L; Zhu L; Zhang R; Zhang J; Yang X; Wang Q; Huang Z; Zou J
    Clin Transl Med; 2022 Sep; 12(9):e1042. PubMed ID: 36116131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway.
    Yu X; Wang M; Zuo J; Wahafu A; Mao P; Li R; Wu W; Xie W; Wang J
    Life Sci; 2019 Nov; 236():116917. PubMed ID: 31614149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saponin 1 induces apoptosis and suppresses NF-κB-mediated survival signaling in glioblastoma multiforme (GBM).
    Li J; Tang H; Zhang Y; Tang C; Li B; Wang Y; Gao Z; Luo P; Yin A; Wang X; Cheng G; Fei Z
    PLoS One; 2013; 8(11):e81258. PubMed ID: 24278406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prolyl isomerase Pin1 regulates the NF-kappaB signaling pathway and interleukin-8 expression in glioblastoma.
    Atkinson GP; Nozell SE; Harrison DK; Stonecypher MS; Chen D; Benveniste EN
    Oncogene; 2009 Oct; 28(42):3735-45. PubMed ID: 19668231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor suppressor PDCD4 inhibits NF-κB-dependent transcription in human glioblastoma cells by direct interaction with p65.
    Hwang SK; Baker AR; Young MR; Colburn NH
    Carcinogenesis; 2014 Jul; 35(7):1469-80. PubMed ID: 24413684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smac mimetic promotes glioblastoma cancer stem-like cell differentiation by activating NF-κB.
    Tchoghandjian A; Jennewein C; Eckhardt I; Momma S; Figarella-Branger D; Fulda S
    Cell Death Differ; 2014 May; 21(5):735-47. PubMed ID: 24488095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of NF-κB and FOSL1 drives glioma stemness.
    Ramar V; Guo S; Hudson B; Khedri A; Guo AA; Li J; Liu M
    Cell Mol Life Sci; 2024 Jun; 81(1):255. PubMed ID: 38856747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NF-κB inhibitor with Temozolomide results in significant apoptosis in glioblastoma via the NF-κB(p65) and actin cytoskeleton regulatory pathways.
    Avci NG; Ebrahimzadeh-Pustchi S; Akay YM; Esquenazi Y; Tandon N; Zhu JJ; Akay M
    Sci Rep; 2020 Aug; 10(1):13352. PubMed ID: 32770097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone Deacetylase Inhibitor RGFP109 Overcomes Temozolomide Resistance by Blocking NF-κB-Dependent Transcription in Glioblastoma Cell Lines.
    Li ZY; Li QZ; Chen L; Chen BD; Wang B; Zhang XJ; Li WP
    Neurochem Res; 2016 Dec; 41(12):3192-3205. PubMed ID: 27632183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of microRNA-128-3p alleviates liver ischaemia-reperfusion injury in mice through repressing the Rnd3/NF-
    Mou T; Luo Y; Huang Z; Zheng D; Pu X; Shen A; Pu J; Li T; Dai J; Chen W; Wu Z
    Innate Immun; 2020 Aug; 26(6):528-536. PubMed ID: 32486927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S100A11 functions as novel oncogene in glioblastoma via S100A11/ANXA2/NF-κB positive feedback loop.
    Tu Y; Xie P; Du X; Fan L; Bao Z; Sun G; Zhao P; Chao H; Li C; Zeng A; Pan M; Ji J
    J Cell Mol Med; 2019 Oct; 23(10):6907-6918. PubMed ID: 31430050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Notch1 is a prognostic factor that is distinctly activated in the classical and proneural subtype of glioblastoma and that promotes glioma cell survival via the NF-κB(p65) pathway.
    Hai L; Zhang C; Li T; Zhou X; Liu B; Li S; Zhu M; Lin Y; Yu S; Zhang K; Ren B; Ming H; Huang Y; Chen L; Zhao P; Zhou H; Jiang T; Yang X
    Cell Death Dis; 2018 Feb; 9(2):158. PubMed ID: 29410396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIM22 activates NF-κB signaling in glioblastoma by accelerating the degradation of IκBα.
    Ji J; Ding K; Luo T; Zhang X; Chen A; Zhang D; Li G; Thorsen F; Huang B; Li X; Wang J
    Cell Death Differ; 2021 Jan; 28(1):367-381. PubMed ID: 32814880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of NF-κB results in anti-glioma activity and reduces temozolomide-induced chemoresistance by down-regulating MGMT gene expression.
    Yu Z; Chen Y; Wang S; Li P; Zhou G; Yuan Y
    Cancer Lett; 2018 Aug; 428():77-89. PubMed ID: 29705182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IGF2 mRNA binding protein 3 (IMP3) promotes glioma cell migration by enhancing the translation of RELA/p65.
    Bhargava S; Visvanathan A; Patil V; Kumar A; Kesari S; Das S; Hegde AS; Arivazhagan A; Santosh V; Somasundaram K
    Oncotarget; 2017 Jun; 8(25):40469-40485. PubMed ID: 28465487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.